By Scott Graham | March 7, 2018
BlackBerry Ltd., which no longer makes its own mobile phones, still holds a trove of mobile technology patents, and on Tuesday it unleashed them against the CrackBerry of the current decade: Facebook, Instagram and WhatsApp.
Litigation Daily | Letter to the Editor
By Jenna Greene | March 6, 2018
Sometimes First Amendment rights to rebut and set the record straight need to be exercised by parties in litigation before a verdict in order to effectively defend reputation on a timely basis.
By Jenna Greene | February 28, 2018
There's litigating in the court of public opinion—and then wow. There's this case.
By Scott Graham | February 26, 2018
Jamie Underwood is the second addition to Latham's ITC practice in the last six months.
By Scott Graham | February 23, 2018
The decision ends—for now—a controversy that erupted last summer when Allergan paid the Saint Regis Mohawk Tribe to assume its Restasis patents in a creative legal strategy to fend off challengers.
By Tom McParland | February 22, 2018
In late 2016, Gilead Sciences Inc. and a Fish & Richardson trial team led by Jonathan Singer were hit with a $2.5 billion jury verdict, the largest ever recorded in a U.S. patent infringement case. Here's how they turned the tables on Merck.
Delaware Business Court Insider | News
By Tom McParland | February 20, 2018
A Delaware federal judge on Feb. 16 overturned a massive $2.5 billion jury verdict against Gilead Sciences Inc., finding that a patent held by a unit of Merck & Co. Inc. was too broad to be valid.
By Scott Graham | February 12, 2018
Lawyers for Arista, led by Tensegrity's Matthew Powers, are the latest to attack assignor estoppel, the equitable doctrine that forbids an inventor who sells his or her patent from then turning around and attacking the patent's validity.
By Scott Graham | February 6, 2018
In an appellate showdown between Fish & Richardson's Juanita Brooks and MoloLamken's Jeffrey Lamken, a Federal Circuit panel seemed swayed by Merck's argument that one bad witness didn't taint the jury's verdict.
By Ross Todd | January 25, 2018
A federal jury found that Ariosa's Harmony test infringed two of Illumina's gene-sequencing patents and left open the possibility of an injunction barring the latest version of the test.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS